Literature DB >> 10515093

Hypothesis: from epidermal barrier dysfunction to atopic disorders.

A Taïeb1.   

Abstract

The rôle of a genetically-impaired epidermal barrier as the primary cause of the rapid increase in prevalence of atopic dermatitis and respiratory atopy is proposed, based on available clinical and experimental data. The subsequently increased exposure to irritants and allergen postnatally in predisposed individuals would lead in a subset of these to a specific TH2 cell activation favouring the development of IgE responses to atopens. Other routes of sensitization are probably important, but skin offers a good target to implement prevention strategies, so far completely ignored in the prophylactic recommendations given to high-risk families. Candidate genes for skin-barrier impairment are possibly those associated with ichthyosis vulgaris and X-linked hypohidrotic ectodermal dysplasia.

Entities:  

Mesh:

Year:  1999        PMID: 10515093     DOI: 10.1111/j.1600-0536.1999.tb06125.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  23 in total

Review 1.  Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms.

Authors:  Peter M Elias; Yutaka Hatano; Mary L Williams
Journal:  J Allergy Clin Immunol       Date:  2008-03-07       Impact factor: 10.793

2.  Barrier repair trumps immunology in the pathogenesis and therapy of atopic dermatitis.

Authors:  Peter M Elias
Journal:  Drug Discov Today Dis Mech       Date:  2008

Review 3.  Abnormal skin barrier in the etiopathogenesis of atopic dermatitis.

Authors:  Peter M Elias; Matthias Schmuth
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

Review 4.  Lipid abnormalities and lipid-based repair strategies in atopic dermatitis.

Authors:  Peter M Elias
Journal:  Biochim Biophys Acta       Date:  2013-10-12

5.  Prevalence of atopic disorders and immunodeficiency in patients with ectodermal dysplasia syndromes.

Authors:  Barry J Mark; Bradley A Becker; Donna R Halloran; Alanna F Bree; Raj Sindwani; Mary D Fete; Kathleen J Motil; Sopheak W Srun; Timothy J Fete
Journal:  Ann Allergy Asthma Immunol       Date:  2012-06       Impact factor: 6.347

Review 6.  Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis.

Authors:  Peter M Elias; Joan S Wakefield
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

Review 7.  Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis.

Authors:  Peter M Elias; Joan S Wakefield
Journal:  J Allergy Clin Immunol       Date:  2014-08-15       Impact factor: 10.793

8.  Maintenance of an acidic stratum corneum prevents emergence of murine atopic dermatitis.

Authors:  Yutaka Hatano; Mao-Qiang Man; Yoshikazu Uchida; Debra Crumrine; Tiffany C Scharschmidt; Esther G Kim; Theodora M Mauro; Kenneth R Feingold; Peter M Elias; Walter M Holleran
Journal:  J Invest Dermatol       Date:  2009-01-29       Impact factor: 8.551

9.  Epidermal barrier dysfunction in non-atopic HIV: evidence for an "inside-to-outside" pathogenesis.

Authors:  Roshan Gunathilake; Matthias Schmuth; Tiffany C Scharschmidt; Robert Gruber; Daniela Grabher; Kieron S Leslie; Toby A Maurer; Theodora M Mauro; Peter M Elias
Journal:  J Invest Dermatol       Date:  2009-11-19       Impact factor: 8.551

10.  Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis.

Authors:  Peter M Elias; Jack Arbiser; Barbara E Brown; Heidemarie Rossiter; Mao-Qiang Man; Francesca Cerimele; Debra Crumrine; Roshan Gunathilake; Eung Ho Choi; Yoshikazu Uchida; Erwin Tschachler; Kenneth R Feingold
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.